Amelioration of sexual adverse effects in the early breast cancer patient

Department of Medicine, University of California San Francisco, 94115, USA.
Journal of Cancer Survivorship (Impact Factor: 3.3). 09/2010; 4(3):247-55. DOI: 10.1007/s11764-010-0130-1
Source: PubMed

ABSTRACT As the number of breast cancer survivors increases, the long term consequences of breast cancer treatment are gaining attention. Sexual dysfunction is a common complaint amongst breast cancer survivors, and there are few evidence based recommendations and even fewer well designed clinical trials to establish what treatments are safe or effective in this patient population.
We conducted a PubMed search for articles published between 1995-2009 containing the terms breast cancer, sexual dysfunction, libido, vaginal dryness, testosterone, and vaginal estrogen. We initially reviewed articles focusing exclusively on sexual issues in breast cancer patients. Given the paucity of clinical trials addressing sexual issues in breast cancer patients, we also included studies evaluating both hormone and non-hormone based interventions for sexual dysfunction in post-menopausal women in general.
Among breast cancer survivors, vaginal dryness and loss of libido represent some of the most challenging long term side effects of breast cancer treatment. In the general post-menopausal population, topical preparations of estrogens and testosterone both appear to improve sexual function; however there are conflicting reports about the efficacy and safety of these interventions in women with a history of breast cancer, and further research is warranted.

Download full-text


Available from: Hope Rugo, Sep 28, 2015
26 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: The purpose of this study was to understand the reported experiences of sexuality among Korean women who are breast cancer survivors. Methods: Participants of this study were 12 women who had breast cancer surgery. Data were collected October, 2010 to January, 2011 through in-depth interviews by using tape-recordings. Data were analyzed with Colaizzi's (1978) phenomenological methodology. Results: From significant statements, four categories, ten theme clusters and 32 themes were extracted from the essential meaning of the sexuality experience as reported by the women participants. Within the four categories were 'Negatively changed in sexuality', 'Feeling of great loss as a woman', 'Changed martial relations with husband', and 'Turning to the happy life'. 'Overcoming sexuality caused by distress and feeling of loss' was united from four categories. Conclusion: The results of this study could help contribute to provide educational program on sexuality to improve sexual well-being and quality of life of women with breast cancer survivors and their spouses.
    Korean Journal of Adult Nursing 01/2011; 23(5).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This review presents an overview of recent developments in research examining coping with the effects of cancer treatment on sexuality. A search was conducted using PubMed and Web of Knowledge to find papers published or in press in 2010. Papers examining coping efforts, effects of cancer treatment in special populations (e.g., advanced cancer, non-western populations), or on broad dimensions of sexuality, and psychosocial and physiological intervention studies addressing sexual issues in cancer were included. Findings underscore the complex effects of treatments (e.g., hormonal therapy for prostate cancer) on patients' sexuality. Studies suggest that successful coping efforts often occur within the context of the relationship and frequently include a process of adjusting one's concept of sexual function and activity through shifting to thoughts and behaviors that center on intimacy and sexual activities other than intercourse (e.g., 'flexible coping'). Results confirm the importance of sexual issues to individuals with cancer and argue for more research on sexual effects of cancer treatment in understudied populations and further empirical studies examining coping with sexual concerns after cancer. Clinical implications include the need for providers to address the broader range of sexual effects of treatments beyond sexual performance.
    Current opinion in oncology 02/2011; 23(4):313-21. DOI:10.1097/CCO.0b013e3283446416 · 4.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In breast cancer patients, menopausal symptoms such as hot flashes, urogenital problems, musculoskeletal symptoms and cognitive dysfunction are common, regardless of age at diagnosis. They affect quality of life and systemic therapy will worsen this. Endocrine and/or chemotherapy may induce temporary or permanent ovarian failure and can exacerbate these symptoms. Hormone therapy (HT) has been studied in breast cancer survivors, but safety has been questioned. The HABITS trial investigating estrogen-based HT, as well as the LIBERATE trial investigating tibolone, found a reduction in disease-free survival for those treated. Alternative strategies are needed, as menopause symptoms may reduce compliance with breast cancer treatments. This article reviews recently published strategies to tackle menopausal problems in breast cancer patients. Antidepressants may help with hot flashes. Acupuncture and hypnosis can also be used but the evidence is conflicting. For urogenital problems vaginal moisturizers or topical estrogens can be employed. A musculoskeletal syndrome induced by aromatase inhibitors (AIs) is frequently encountered and currently there are no effective treatment strategies. Bisphosphonates reduce AI-induced bone resorption and can also increase disease-free and overall survival. Standard-dose endocrine and chemotherapy are associated with a decline in cognitive function.
    Maturitas 02/2011; 68(2):148-54. DOI:10.1016/j.maturitas.2010.11.013 · 2.94 Impact Factor
Show more